Please login to the form below

US drug prices

This page shows the latest US drug prices news and features for those working in and with pharma, biotech and healthcare.

Pfizer CEO reckons rebates will disappear, and that’s a positive

Pfizer’s chief executive Ian Read (pictured below) has said that he expects drug price rebates will eventually disappear in the US, and that could give drugs like arthritis drug Xeljanz ... Abandoning rebates could deliver a situation where drug prices

Latest news

Merck & Co joins big pharma pricing pledge – but sceptics unconvinced

Pfizer CEO Ian Read hand a lengthy telephone call about drug prices. ... Let’s keep reality in focus: Drug companies don’t get credit for keeping prices high.
Daily Brief: Calls for early Brexit deal for science and innovation, Gottlieb threatens to name and shame

US drug prices. FDA’s ‘name and shame’website goes live tomorrow. FDA Commissioner Scott Gottlieb (pictured) has warned that pharma companies which block the launch of generic competitors will be ... Azar, to crack down on loopholes and abuses
Novartis, Amgen set low price for first CGRP migraine drug

months. Aimovig (erenumab) has been cleared by the US regulator as a once-monthly, self-injected preventive treatment for migraines based on data from three clinical trials which showed the drug ... The co-pay burden is one of the key targets in
FDA ‘names and shames’ generic-blocking pharma companies

The obstructive practices were referred to as ‘gaming’in President Trump’s blueprint document which was unveiled last Friday and aims to cut medicine prices. ... We’re taking these steps today because we believe greater transparency will help
Daily Brief: Azar blasts pharma, NICE forces MS drug prices down, Xenicos gets $30m funding

Daily Brief: Azar blasts pharma, NICE forces MS drug prices down, Xenicos gets $30m funding. ... sector. US drug prices. After Trump bluster, Azar gets serious on drug prices.

More from news
Approximately 2 fully matching, plus 16 partially matching documents found.

Latest Intelligence

Deal Watch January 2017

bear on US drug prices and the possible revocation of Obamacare in part, if not in full. ... 230. Cymabay. Kowa. Exclusive licence in the US. Arhalofenate for gout p3 ready.
Tracking comms trends: Europe in the global vanguard on value

But this is changing. President Obama, plus candidates Donald Trump and Hillary Clinton, have all proposed that Medicare should negotiate drug prices. ... More locally, US HMOs and insurance funds are using levels of HTA and deploying cost containment
Social media and inflation penalties for generic drugs

Social media and inflation penalties for generic drugs. US generic drug companies are under more scrutiny as the US public becomes more vocal . ... In reality, the omission of a similar inflation penalty for generics has allowed drug prices in that
The price is right?

Drug pricing is currently taking centre stage in the lead up to the 2016 US Presidential Election. ... Hillary Clinton's pitch to become the Democrat candidate has majored heavily on tackling 'runaway prescription drug prices' - and the intensity of her
Country report: The healthcare market in South Korea

This is a vaguely defined concept; drug prices in the US average more than twice as high as in many other wealthy countries. ... The single insurer aim is to reduce prices by 20 per cent and these cannot exceed those in main markets such as France,

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Account Director – Global Healthcare PR: Salary TBC

Associate Medical Director: Highly Competitive

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Experienced Editor, London, Medical Communications: Competitive package

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Associate Medical Director: Salary TBC

Account Manager, Healthcare Advertising: Salary TBC

Account Manager, Healthcare Communications: £32, 000 - £40, 000 benefits

Scientific Director: Highly Competitive Salary &Benefits

Director Healthcare PR Communications: Salary TBC

Editorial Director – Medical Education: Neg

Account Manager- Manchester, Macclesfield or Glasgow: Negotiable

Lead Medical Copywriter, Healthcare Brand Communications, London: Excellent package

Senior Account Manager - Med Comms: Highly Competitive Salary &Benefits

Account Director: Negotiable

Account Director - Digital: Great salary and benefits

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Senior Account Executive – Medical Communications: Salary TBC

Senior Medical Writer (Remote Working): Competitive Salary Offered

Medical Strategic Director, Healthcare Advertising Agency: Salary TBC

Director – Head of Public Affairs: Neg

Scientific Team Lead: Competitive Salary

Project / Account Manager (Medical Education): Salary TBC

Senior Account Manager / Account Director - Med Comms: Great salary and benefits

Subscribe to our email news alerts

PMHub

Add my company

3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Retaining reader value in plain language summaries of clinical studies: Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?: Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds: A vision of Paris as Europe's leading hub for life sciences innovation...